Abstract
Cannabis sativa has been used as an anti-inflammatory plant for millennia. However until the elucidation of the chemistry of its constituents and the discovery of the endogenous cannabinoid system only a limited amount of research had been done on the effects of the plant or its constituents on inflammation. In the present overview we summarize our work on the effects of the non-psychotropic cannabidiol (CBD) and of a synthetic cannabidiol-derived acid (HU-320) in animal models of arthritis. Both compounds block progression of the disease, when administered after its onset. Cannabidiol was equally effective was administered i.p. or orally. Significant protection of the joints against severe damage was noted. In vitro cannabidiol reduced lymphocyte proliferation, and TNF-α formation and blocked zymosan-triggered production of reactive oxygen intermediates (ROI). Ex vivo lymph node cells from CBD-treated mice showed a decrease of collagen II-specific proliferation and IFN-γ production. A decreased release of TNF by knee synovial cells was also noted. A synthetic cannabidiol derivative, HU-320 also inhibited production of TNF and ROI by mouse macrophages in vitro and suppressed in vivo rise in serum TNF following endotoxin challenge. HU-320 showed no activity in a standard assay for THC-type psychotropic effects. These results suggest that CBD and HU-320 hold promise as potential novel anti-inflammatory agents.
Article PDF
Abbreviations
- 2-AG:
-
2-arachidonoylglycerol
- CBD:
-
cannabidiol
- CIA:
-
collagen-induced arthritis
- CII:
-
collagen type II
- IFN:
-
interferon
- IL:
-
interleukin
- LPS:
-
lipopolysaccharide
- NO:
-
nitric oxide
- ROI:
-
reactive oxygen intermediates
- THC:
-
tetrahydrocannabinol
- TNF:
-
tumor necrosis factor
References
R Adams (1941–1942) ArticleTitleMarihuana Harvey Lect 37 168–197
S Agurell M Halldin JE Lingren A Ohlsson M Widman H Gillespie L Hollister (1986) ArticleTitlePharmacokinetics and metabolism of delta-1-tetrahydrocannabinol and other cannabinoids with emphasis on man Pharmacol. Revs 38 21–43
TF Brunner (1973) ArticleTitleMarijuana in ancient Greece and Rome? The literary evidence Bull. Hist. Med 47 344–355 Occurrence Handle4589521
Burstein S (1989) Delta-1-THC-7-oic Acid and Analgetic and Anti-inflammatory Agents. US Patent 4,847,290
SH Burstein CA Audette A Breuer WA Devane S Colodner SA Doyle R Mechoulam (1992) ArticleTitleSynthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic and leukocyte anti-adhesion activities J. Med. Chem 35 3135–3141 Occurrence Handle10.1021/jm00095a007 Occurrence Handle1507202
Burstein (2001) ArticleTitleAjulemic acid. Drugs Future 26 342–345 Occurrence Handle10.1358/dof.2001.026.04.615769
S Burstein (2001) Therapeutic potential of ajulemic acid (CT3) F Grotenherman E. Russo (Eds) Cannabis and Cannabinoids Haworth Press New York 381–388
GA Cabral KN Harmon SJ Carlisle (2001) ArticleTitleCannabinoid-mediated inhibition of inducible nitric oxide production by rat microglial cells: Evidence for CB1 receptor participation Adv. Exp. Med. Biol 493 207–214 Occurrence Handle11727767
R Campbell Thompson (1949) A Dictionary of Assyrian Botany The British Academy London 220–222
IC Chopra RN Chopra (1957) ArticleTitleThe use of cannabis drugs in India Bull. Narc 9 4–29
A Christison (1851) ArticleTitleOn the natural history, action and uses of Indian hemp Monthly J. Med. Sci 13 26–45
EZ Dajani KR Larsen J Taylor NE Dajani TG Shahwan SD Neeleman MS Taylor MT Dayton GN Mir (1999) ArticleTitle1,1-dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: A novel orally effective cannabinoid with analgesic and anti-inflammatory properties J. Pharmacol. Exp. Ther 291 31–38 Occurrence Handle10490883
WA Devane FA Dysarz Suffix3rd MR Johnson LS Melvin AC Howlett (1988) ArticleTitleDetermination and characterization of a cannabinoid receptor in rat brain Mol. Pharmacol 34 605–613 Occurrence Handle2848184
WA Devane A Breuer T Sheskin TUC Jarbe M Eisen R Mechoulam (1992a) ArticleTitleA novel probe for the cannabinoid receptor J. Med. Chem 35 2065–2069 Occurrence Handle10.1021/jm00089a018
WA Devane L Hanus A Breuer RG Pertwee LA Stevenson G Griffm D Gibson A Mandelbaum A Etinger R Mechoulam (1992b) ArticleTitleIsolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1946–1949
Dioscorides (1934) The Greek Herbal. In: Gunther RT, (ed) Oxford University Press, pp. 390–391, plant drawings 165 and 166
M Donovan (1845) ArticleTitleOn the physical and medicinal qualities of Indian hemp (Cannabis indica) Dublin J. Med. Sci 26 368–402
EA Formukong AT Evans FJ Evans (1988) ArticleTitleAnalgesic and anti-inflammatory activity of constituents of Cannabis sativa L Inflammation 12 361–371 Occurrence Handle10.1007/BF00915771 Occurrence Handle3169967
E Fride R Mechoulam (1993) ArticleTitlePharmacological activity of the cannabinoid agonist anandamide, a brain constituent Eur. J. Pharmacol 231 313–314 Occurrence Handle10.1016/0014-2999(93)90468-W Occurrence Handle8384116
Y Gaoni R Mechoulam (1964) ArticleTitleIsolation structure and partial synthesis of active constituent of hashish J. Amer. Chern. Soc 86 1646–1647 Occurrence Handle10.1021/ja01062a046
AJ Hampson M Grimaldi J Axelrod D Wink (1998) ArticleTitleCannabidiol and (-)delta(9)-tetrahydrocannabinol are neuroprotective antioxidants Proc. Natl. Acad. Sci. (USA) 95 8268–8273 Occurrence Handle10.1073/pnas.95.14.8268
AC Howlett RM Fleming (1984) ArticleTitleCannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes Mol. Pharmacol 26 532–538 Occurrence Handle6092901
AC Howlett TM Champion GH Wilken R Mechoulam (1990) ArticleTitleStereochemical effects of 11-OH-delta-8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor Neuropharmacol 291 161–165 Occurrence Handle10.1016/0028-3908(90)90056-W
AC Howlett F Barth TI Bonner G Cabral P Casellas WA Devane CC Felder M Herkenham K Mackie BR Martin R Mechoulam RG Pertwee (2002) ArticleTitlelnternation Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol. Rev 54 161–202 Occurrence Handle10.1124/pr.54.2.161 Occurrence Handle12037135
TW Klein C Newton K Larsen L Lu I Perkins L Nong H Friedman (2003) ArticleTitleThe cannabinoid system and immune modulation J. Leukoc. Biol 74 486–489 Occurrence Handle10.1189/jlb.0303101 Occurrence Handle12960289
DM Lambert S Vandevoorde KO Jonsson CJ Fowler (2002) ArticleTitleThe palmitoylethanolamide family: A new class of anti-inflammatory agents? Curr. Med. Chem 9 663–674 Occurrence Handle11945130
AM Malfait R Gallily PF Sumariwalla AS Malik E Andreakos R Mechoulam M Feldmann (2000) ArticleTitleThe non-psychoactive cannabis-constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Proc. Natl. Acad. Sci. (USA) 97 9561–9566 Occurrence Handle10.1073/pnas.160105897
LA Matsuda SJ Lolait MJ Brownstein AC Young TI Bonner (1990) ArticleTitleStructure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 561–564 Occurrence Handle10.1038/346561a0 Occurrence Handle2165569
Mechoulam R, Gaoni Y (1967) The absolute configuration of Δ1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahededron Lett. 1109–1111
R Mechoulam (1970) ArticleTitleMarihuana chemistry Review. Science 168 1159–1166
R Mechoulam Z Ben-Zvi S Agurell IM Nilsson JLG Nilsson H Edery Y Grunfeld (1973) ArticleTitleDelta-6-tetrahydrocannabinol-7-oic acid, a urinary delta-6-THC metabolite – isolation and synthesis Experientia 29 1193–1195 Occurrence Handle10.1007/BF01935065 Occurrence Handle4758913
R. Mechoulam (1986) The Pharmacohistory of Cannabis sativa R Mechoulam (Eds) Cannabinoids as Therapeutic Agents CRC Press, Inc Boca Raton Fl 1–19
R Mechoulam JJ Feigenbaum N Lander M Segal TUC Jarbe AJ Hiltunen P Consroe (1988) ArticleTitleEnantiomeric cannabinoids: Stereospecificity of psychotropic activity Experientia 44 762–764 Occurrence Handle3416993
R Mechoulam S Ben-Shabat L Hanus M Ligumsky NE Kaminski AR Schatz A Gopher S Almog BR Martin DR Compton (1995) ArticleTitleIdentification of a andogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol 50 83–90 Occurrence Handle10.1016/0006-2952(95)00109-D Occurrence Handle7605349
R Mechoulam S Ben-Shabat (1999) ArticleTitleFrom gan-zi-gun-nu to anandamide and 2-arachidonoyl-glycerol, the ongoing story of Cannabis Nat. Prod. Rep 16 131–143 Occurrence Handle10.1039/a703973e Occurrence Handle10331283
R Mechoulam L. Hanus (2002) ArticleTitleCannabidiol: An overview of some chemical and pharmacological aspects. Part I: Chemical Aspects Chem. Phys. Lipids 121 35–43 Occurrence Handle10.1016/S0009-3084(02)00144-5 Occurrence Handle12505688
R Mechoulam LA Parker R Gallily (2002) ArticleTitleCannabidiol: An overview of some pharmacological aspects J. Clin. Pharmacol 42 11S–19S Occurrence Handle12412831
D Melck T Bisogno L De-Petrocellis P Beaulieu AS Rice V Di Marzo (2002) ArticleTitleCannabimimetic eicosanoids in cancer and inflammation: an update Adv. Exp. Med. Biol 507 381–386 Occurrence Handle12664614
S Munro KL Thomas M Abu-Shaar (1993) ArticleTitleMolecular characterization of a peripheral receptor for cannabinoids Nature 365 61–65 Occurrence Handle10.1038/365061a0 Occurrence Handle7689702
O’Shaugnessy WB (1843) On the preparations of the Indian hemp, or Gunjah. Trans. Med. Physical Soc. Bengal, 421–461
MH Rhee Z Vogel J Barg M Bayewitch R Levy L Hanus A Breuer R Mechoulam (1997) ArticleTitleCannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase J. Med. Chem 40 3228–3233 Occurrence Handle10.1021/jm970126f Occurrence Handle9379442
Rosenkrantz H, Fleischman RW, Grant RJ (1981) Toxicity of short-term administration of cannabinoids to rhesus monkeys. Toxicol. Ap
MD Roth GC Baldwin DP Tashkin (2002) ArticleTitleEffects of delta-9-tetrahydrocannabinol on human immune function and host defense Chem. Phys. Lipids 121 229–239 Occurrence Handle10.1016/S0009-3084(02)00159-7 Occurrence Handle12505703
J Russel Reynolds (1890) ArticleTitleTherapeutic uses and toxic effects of Cannabis indica Lancet 1 637–638 Occurrence Handle10.1016/S0140-6736(02)18723-X
R Sancho MA Calzado V Di Marzo G Appendino E Munoz (2003) ArticleTitleAnandamide inhibits nuclear factor-KB activation through a cannabinoid receptor-independent pathway Mol. Pharmacol 63 429–438 Occurrence Handle10.1124/mol.63.2.429 Occurrence Handle12527815
MD Srivastava BI Srivastava B Brouhard (1998) ArticleTitleDelta- 9-tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells Immunopharmacol 40 179–1885 Occurrence Handle10.1016/S0162-3109(98)00041-1
T Sugiura S Kondo A Sukagawa S Nakane A Shinoda K Itoh A Yamashita K Waku (1995) ArticleTitle2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem. Biophys. Res. Commun 215 89–97 Occurrence Handle10.1006/bbrc.1995.2437 Occurrence Handle7575630
E Sulcova R Mechoulam E Fride (1998) ArticleTitleBiphasic effects ofanandamide Pharmacol. Biochem. Behav 59 347–353 Occurrence Handle10.1016/S0091-3057(97)00422-X Occurrence Handle9476980
Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M (2004) A novel synthetic non-psychoactive cannabinoid acid (HU-320) with anti-inflammatory properties in murine collagen-induced arthritis. Arthritis Rheumat. (in press)
AR Todd (1946) ArticleTitleHashish Experientia 2 55–60
CE Turner MA Elsohly EG Boeren (1980) ArticleTitleConstituents of Cannabis sativa L. XVII. A review of the natural constituents J. Nat. Prod 43 169–234 Occurrence Handle10.1021/np50008a001 Occurrence Handle6991645
B Watzl P Scuderi RR Watson (1991) ArticleTitleMarijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro Int. J. Immunopharmacol 13 1091–1097 Occurrence Handle1667651
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Mechoulam, R., Sumariwalla, P.F., Feldmann, M. et al. Cannabinoids in Models of Chronic Inflammatory Conditions. Phytochem Rev 4, 11–18 (2005). https://doi.org/10.1007/s11101-004-1534-1
Issue Date:
DOI: https://doi.org/10.1007/s11101-004-1534-1